ES8403440A1 - Procedimiento para preparar derivados de guanidina. - Google Patents

Procedimiento para preparar derivados de guanidina.

Info

Publication number
ES8403440A1
ES8403440A1 ES519401A ES519401A ES8403440A1 ES 8403440 A1 ES8403440 A1 ES 8403440A1 ES 519401 A ES519401 A ES 519401A ES 519401 A ES519401 A ES 519401A ES 8403440 A1 ES8403440 A1 ES 8403440A1
Authority
ES
Spain
Prior art keywords
alkyl
ring
alkyls
cycloalkyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES519401A
Other languages
English (en)
Other versions
ES519401A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES519401A0 publication Critical patent/ES519401A0/es
Publication of ES8403440A1 publication Critical patent/ES8403440A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE GUANIDINA Y DE SUS SALES DE ADICION DE ACIDO FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R1, R2, R3, R4 Y A PUEDEN SER VARIOS TIPOS DE RADICALES; Y EN EL ANILLO X LA LINEA DISCONTINUA EN UN DOBLE ENLACE EN UN LADO DEL N Y Z ES C O N.CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II), EN LA QUE R13 ES UN RADICAL DESPLAZABLE Y LOS DEMAS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I), CON UN COMPUESTO QUE TIENE UNA CADENA DE 2-3 ATOMOS, EN EL QUE LA CADENA ESTA FUNCIONALIZADADE MODO QUE SE FORMA UNA AMIDINA CICLIZADA.ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE ULCERAS PEPTICAS Y OTROS ESTADOS PRODUCIDOS POR LA ACIDEZ GASTRICA.
ES519401A 1981-03-18 1983-01-31 Procedimiento para preparar derivados de guanidina. Expired ES8403440A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8108407 1981-03-18
GB8132680 1981-10-29

Publications (2)

Publication Number Publication Date
ES519401A0 ES519401A0 (es) 1984-03-16
ES8403440A1 true ES8403440A1 (es) 1984-03-16

Family

ID=26278795

Family Applications (4)

Application Number Title Priority Date Filing Date
ES510583A Granted ES510583A0 (es) 1981-03-18 1982-03-18 Derivados de guanidina.
ES519402A Expired ES8406424A1 (es) 1981-03-18 1983-01-31 Procedimiento para preparar derivados de guanidina.
ES519401A Expired ES8403440A1 (es) 1981-03-18 1983-01-31 Procedimiento para preparar derivados de guanidina.
ES519403A Granted ES519403A0 (es) 1981-03-18 1983-01-31 Procedimiento para preparar derivados de guanidina.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES510583A Granted ES510583A0 (es) 1981-03-18 1982-03-18 Derivados de guanidina.
ES519402A Expired ES8406424A1 (es) 1981-03-18 1983-01-31 Procedimiento para preparar derivados de guanidina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES519403A Granted ES519403A0 (es) 1981-03-18 1983-01-31 Procedimiento para preparar derivados de guanidina.

Country Status (18)

Country Link
US (1) US4795755A (es)
EP (1) EP0060697B1 (es)
AU (1) AU556079B2 (es)
CA (1) CA1200549A (es)
DD (1) DD202552A5 (es)
DE (1) DE3274856D1 (es)
DK (1) DK121282A (es)
ES (4) ES510583A0 (es)
FI (1) FI820882L (es)
GR (1) GR76470B (es)
IE (1) IE52764B1 (es)
IL (1) IL65160A (es)
IN (1) IN158869B (es)
NO (1) NO820870L (es)
NZ (1) NZ200042A (es)
PL (1) PL137088B1 (es)
PT (1) PT74599B (es)
ZW (1) ZW3682A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1233818A (en) * 1981-03-09 1988-03-08 David J. Gilman Guanidine derivatives as histamine h-2 receptor antagonists
CA1211111A (en) * 1982-02-15 1986-09-09 Isao Yanagisawa Process for preparing novel pyrimidone compounds
US4808589A (en) * 1982-02-20 1989-02-28 Smith Kline & French Laboratories Limited Pyrimidone derivatives
GB8316779D0 (en) * 1982-09-07 1983-07-27 Ici Plc Process
US4585781A (en) * 1982-12-31 1986-04-29 Glaxo Group Limited Heterocyclic derivatives
GB8401751D0 (en) * 1984-01-24 1984-02-29 Ici Plc Guanidine derivatives
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
WO1994026715A1 (en) * 1993-05-11 1994-11-24 Smithkline Beecham Plc Amidine derivatives as gastric acid secretion inhibitors
EP2822931B1 (en) 2012-03-09 2017-05-03 Inception 2, Inc. Triazolone compounds and uses thereof
US9676754B2 (en) 2012-12-20 2017-06-13 Inception 2, Inc. Triazolone compounds and uses thereof
CA2921420A1 (en) 2013-09-06 2015-03-12 Inception 2, Inc. Triazolone compounds and uses thereof
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA782129B (en) * 1977-04-20 1979-03-28 Ici Ltd Hertocyclic derivatives
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
GB2001624B (en) * 1977-04-20 1982-03-03 Ici Ltd Guanidine derivatives processes for their manufacture and pharmaceutical compositions containing them
BE866155A (fr) * 1977-04-20 1978-10-19 Ici Ltd Nouveaux derives de la guanidine
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
EP0003640B1 (en) * 1978-01-18 1982-01-27 Imperial Chemical Industries Plc Antisecretory guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
DE2963363D1 (en) * 1978-05-24 1982-09-09 Ici Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
EP0014057B1 (en) * 1979-01-18 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
JPS6056143B2 (ja) * 1979-08-02 1985-12-09 山之内製薬株式会社 アミジン誘導体ならびにその製造法
PH16099A (en) * 1979-03-06 1983-06-24 Yamanouchi Pharma Co Ltd Guanidinothiazole compounds,process for preparing them and medical composition containing them
US4242351A (en) * 1979-05-07 1980-12-30 Imperial Chemical Industries Limited Antisecretory oxadiazoles and pharmaceutical compositions containing them
GR71929B (es) * 1979-11-13 1983-08-19 Ici Ltd
FI73423C (fi) * 1980-02-29 1987-10-09 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av farmakologiskt verksamma tetrazolderivat.
EP0045155B1 (en) * 1980-07-30 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives
GB2085871B (en) * 1980-08-08 1984-07-25 Kotobuki Seiyaku Co Ltd New 3-substituted-2-propenimidamides and method of manufacturing the same
JPS5775975A (en) * 1980-08-27 1982-05-12 Glaxo Group Ltd Heterocyclic derivative, manufacture and medicinal composition containing same

Also Published As

Publication number Publication date
ES519401A0 (es) 1984-03-16
FI820882L (fi) 1982-09-19
PL137088B1 (en) 1986-04-30
ES8306476A1 (es) 1983-06-01
ES8403441A1 (es) 1984-03-16
NO820870L (no) 1982-09-20
EP0060697A1 (en) 1982-09-22
EP0060697B1 (en) 1986-12-30
AU8113782A (en) 1982-09-23
IN158869B (es) 1987-02-07
DK121282A (da) 1982-09-19
ZW3682A1 (en) 1983-10-26
PL235453A1 (en) 1983-03-28
CA1200549A (en) 1986-02-11
IE820394L (en) 1982-09-18
ES510583A0 (es) 1983-06-01
ES519402A0 (es) 1984-07-16
ES8406424A1 (es) 1984-07-16
GR76470B (es) 1984-08-10
PT74599A (en) 1982-04-01
IL65160A (en) 1986-04-29
IE52764B1 (en) 1988-02-17
DE3274856D1 (en) 1987-02-05
DD202552A5 (de) 1983-09-21
NZ200042A (en) 1985-08-30
PT74599B (en) 1983-11-07
US4795755A (en) 1989-01-03
ES519403A0 (es) 1984-03-16
AU556079B2 (en) 1986-10-23

Similar Documents

Publication Publication Date Title
ES8406424A1 (es) Procedimiento para preparar derivados de guanidina.
ES8306141A1 (es) Un procedimiento para la produccion de un derivado de carbostirilo
IL107426A (en) 3-HALO-8-ARALKOXY (OR ARALKYLAMINO) IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ES8402561A1 (es) Procedimiento para preparar derivados de guanidina.
GR3015194T3 (en) Indolocarbazole derivatives, process for their preparation and medicines containing same.
AU531282B2 (en) Heterocyclic oxypropanolamine derivatives
ES8501368A1 (es) Procedimiento para preparar derivados de n-fenil-benzamida
BG100154A (en) Carbazole derivatibes having inhibiting effect to 17,20-lyase
RU97103983A (ru) Лекарственные композиции и производные триазина
IE820685L (en) Guanidinoheterocyclic derivatives as histamine h-2¹antagonists
TW366343B (en) Piperidine derivatives and anti-platelet agents containing the same
AU540916B2 (en) 3,1 benzoxazin-2-ones
IL63381A0 (en) 5-substituted 5,10-dihydro-11h-dibenzo(b,e)(1,4)diazepin-11-one derivatives,their preparation and pharmaceutical compositions containing them
ES8500221A1 (es) Procedimiento para preparar derivados de guanidina.
AU565519B2 (en) Pyridyl piperidinedione derivatives and their use as anti-arrhythmics
BR8400549A (pt) Derivados e sais inertes de hidroxido de aminopiridinios e processos de preparacao;e composicao farmaceutica
ES8404785A1 (es) Procedimiento para la fabricacion de nicotinamida 1-oxido n-substituida y sus sales
ES8103047A1 (es) Procedimiento de preparacion de derivados aminoisoquinolinosasi como de sus sales de adicion acidas, farmaceuticamente aceptables y de sus derivados amonicos cuaternarios
ES8203869A1 (es) Un procedimiento para la preparacion de nuevos eteres de 1-(2-propiniloxi)-2-amino-3-propanol.
EP0233287A4 (en) 1,4-THIAZINE DERIVATIVES, THEIR PREPARATION AND CARDIOTONIC PROCESSES CONTAINING THEM.
PT73274A (en) Process for preparing new naphthimidazole and naphthoxazole derivatives and pharmaceutical compositions containing the same